Drugs / PEG 180 μg administered via subcutaneous (s.c.) injection once weekly
PEG 180 μg administered via subcutaneous (s.c.) injection once weekly
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01318694 Background | Mar 2011 → Aug 2013 | chronic hepatitis C virus infection | Debiopharm International SA | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PEG 180 μg administered via subcutaneous (s.c.) injection once weekly | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01318694 ↗ |